Analyst Ratings for MBX Biosciences Inc (MBX)
MBX Rating Summary
MBX Price Target Summary
- Highest: $150.00 (Guggenheim)
- Lowest: $18.00 (Goldman Sachs)
- Average: $84.45
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$84.45 (+74.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$84.45 (+74.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/21/2026 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
88.00 (N/A) |
68.40 (48.50) |
-29.09% | Details |
| 5/4/2026 | Oppenheimer | Leland Gershell | New Coverage | Outperform (N/A) |
80.00 (N/A) |
29.78 (48.50) |
62.86% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
